Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Brand name: Atenolol (AN) TM
Active ingredients: atenolol
On January 29, 2019 Atenolol (AN) was not listed on the Australian Register of Therapeutic Goods (ARTG).
Healthdirect medicine data is refreshed once a month, see Data sources page. The medicine you searched for may have been added to the ARTG after this date.
Ask your pharmacist, doctor or health professional for advice, or search the ARTG.
Is this medicine available in Australia?
The ARTG is the register of all therapeutic goods that can be lawfully supplied in Australia. Sometimes a special provision is made to make available some medicines that are not listed in response to the needs of particular people or circumstances. To find out more check out the "Access to therapeutic goods not on the ARTG" section on the ARTG page.
Other medicines that contain: atenolol
Need more information?
These trusted information partners have more on this topic.
Top results
Beta blockers: Medicines for high blood pressure
Read more on Heart Foundation website
Potassium - Lab Tests Online AU
Why and when to get tested for potassium
Read more on Lab Tests Online website
PBS for pharmacists - Australian Government Department of Human Services
Department of Human Services can grant pharmacists approval to supply Pharmaceutical Benefits Scheme (PBS) subsidised items in accordance with section 90 of the National Health Act 1953.
Read more on Medicare website
Essential tremor (shaking) information | myVMC
Essential tremor is a neurological disorder characterised by involuntary twitching of the arms. It causes social and functional impairment.
Read more on myVMC – Virtual Medical Centre website
Long QT syndrome | Sydney Children's Hospitals Network
What is Long QT Syndrome? Long QT syndrome (LQTS) is a heart rhythm disorder, which can cause periods of abnormally fast heart rhythm called arrhythmias
Read more on Sydney Children's Hospitals Network website
CPVT - Catecholaminergic Polymorphic Ventricular Tachycardia | Sydney Children's Hospitals Network
What is CPVT? Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) is a rare heart rhythm disorder, which can cause periods of abnormally fast heart rhythm called arrhythmias
Read more on Sydney Children's Hospitals Network website
Extemporaneously compounded medicines | Issue 1 | Volume 40 | Australian Prescriber
Compounded medicines are not generally assessed for safety and efficacy. Read more about their regulation and short-term expiry dates.
Read more on Australian Prescriber website
Returning unwanted medicinesto pharmacies: prescribing toreduce waste | Australian Prescriber
The Return Unwanted Medicines Project is a free and safe way for consumers to dispose of unwanted medicines at...
Read more on Australian Prescriber website
Angina - myDr.com.au
Angina can affect people in different ways and the symptoms may vary at different times. It usually lasts only a few minutes and can be relieved by rest and/or medicines.
Read more on myDr website
High blood pressure treatments - myDr.com.au
If you have high blood pressureyour doctor may recommendlifestyle measures,such as diet and exercise, and possibly alsomedicines to control your blood pressure. Find out about
Read more on myDr website
Top results
Beta-1 selective blockers for treatment of high blood pressure | Cochrane
Beta-1 selective blockers are a subclass of beta blockers that are commonly used to treat high blood pressure. Drugs in this class include atenolol (Tenormin), metoprolol (Lopressor), nebivolol (Bystolic) and bisoprolol (Zebeta, Monocor). We developed a comprehensive methodology to examine how different doses and drugs in this class of drugs lower blood pressure.
Read more on Cochrane (Australasian Centre) website
Beta blockers for peripheral arterial disease | Cochrane
Intermittent claudication, the most common symptom of atherosclerotic peripheral arterial disease, results from decreased blood flow to the legs during exercise. Beta blockers, a large group of drugs, have been shown to decrease death among people with high blood pressure and coronary artery disease and are used to treat various disorders. They reduce heart activity but can also inhibit relaxation of smooth muscle in blood vessels, bronchi and the gastrointestinal and genitourinary tracts. The non-selective beta blockers propranolol, timolol and pindolol are effective at all beta-adrenergic sites in the body, whereas other beta blockers, such as atenolol and metoprolol, are selective for the heart.
Read more on Cochrane (Australasian Centre) website
Beta-blockers for hypertension | Cochrane
Read more on Cochrane (Australasian Centre) website
Treatment of high blood pressure for people with peripheral arterial disease | Cochrane
When blood pressure is consistently high it can lead to complications such as a heart attack (myocardial infarction) or stroke. Both peripheral arterial disease (PAD), a condition that affects the blood vessels (arteries) carrying the blood to the legs, arms, and stomach area, and high blood pressure (hypertension) are associated with atherosclerosis. This is hardening of the arteries which is caused by deposits of fat, cholesterol and other substances inside the blood vessels. PAD is diagnosed when the blood supply to the legs is restricted causing pain and cramping that limits walking (intermittent claudication). It is measured by the walking distance (on a treadmill) before onset of pain (claudication distance) or ankle brachial index (ABI), the ratio of the blood pressure in the arms to the blood pressure in the legs. If the blood pressure is lower in the legs compared to the arms (ABI of less than 1.0) this indicates blocked arteries in the legs (or PAD). PAD can progress to pain at rest and critical limb ischaemia (sudden lack of blood flow to a limb caused by a blood clot or fatty deposit blockage) that requires revascularisation (restoring the blood flow by opening up the blocked blood vessel) or amputation. Treatment of hypertension to reduce cardiovascular events (heart attack or stroke) and death needs careful consideration in people with PAD. Anti-hypertensive medications may worsen the PAD symptoms by further reducing blood flow and supply of oxygen to the limbs, and may have long-term effects on disease progression. The evidence from randomised controlled trials (RCTs) examining the risks and benefits of various anti-hypertensive drugs on measures of PAD is lacking.
Read more on Cochrane (Australasian Centre) website
Medical management of chronic stable angina | Issue 4 | Volume 38 | Australian Prescriber
Stable angina pectoris is characterised by typical exertional chest pain that is relieved by rest or nitrates.Risk stratification of patients is important to...
Read more on Australian Prescriber website
